Literature DB >> 6204249

Aphasia and right hemiplegia after cervical myelography with metrizamide. A case report.

P Angiari, G Crisi, G A Merli.   

Abstract

We report a case of aphasia and right hemiplegia, developing after myelography with metrizamide and lasting for an unusually long time. The neurological disorders, manifested 1 h after the examination was completed, were due to accidental passage of contrast medium into the basal cisterns. In the light of analogous case reports in the literature, as well as experimental data concerning the biochemical activity of metrizamide, possible aetiopathogenetic mechanisms responsible for such disturbances are indicated. The authors underline the lack of effective therapeutic measures after the onset of the disorders, and thus the importance of preventing such complications that behave functionally as true ictuses although with no anatomic substratum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204249     DOI: 10.1007/bf00328207

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  3 in total

1.  [Cerebral penetration following metrizamide myelography].

Authors:  J M Caillé; F Guibert-Tranier; J M Howa; J Billerey; A Calabet; J Piton
Journal:  J Neuroradiol       Date:  1980       Impact factor: 3.447

2.  Serious neurological complications of metrizamide myelography. Report of eight cases.

Authors:  L Picard; H Vespignani; P Vieux-Rochat; C Moret; G L'espérance; J Montaut; M Wéber; J Roland
Journal:  J Neuroradiol       Date:  1979       Impact factor: 3.447

3.  [Motor aphasia after cervical myelography with metrizamide (author's transl)].

Authors:  D K Böker; K Sartor; D Winkler
Journal:  Rofo       Date:  1980-08
  3 in total
  1 in total

1.  Electrophysiological and cognitive effects of lumbar myelography with iopamidol: comparison with diagnostic lumbar puncture.

Authors:  L Provinciali; M G Ceravolo; M Signorino; M Baroni; U Pasquini; R Cerrutti; U Salvolini
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.